COVID-19 In-Hospital Mortality Rate is Reduced by Prophylactic Use of Ivermectin: Findings From a City-Wide, Prospective Observational Study Using Propensity Score Matching (PSM)
et al., Research Gate, doi:10.13140/RG.2.2.26793.52327 (Preprint)
, COVID-19 In-Hospital Mortality Rate is Reduced by Prophylactic Use of Ivermectin: Findings From a City-Wide,.., Research Gate, doi:10.13140/RG.2.2.26793.52327 (Preprint)
PSM retrospective 378 hospitalized patients in Brazil, showing lower mortality for patients that were on ivermectin prophylaxis before admission (not taking into account the lower risk of being hospitalized shown in the related larger study).
This study is excluded in meta
analysis:
patients in this study are a subset of those in a larger study; not taking into account the lower risk of hospitalization shown in the related larger study.
|
risk of death, 45.0% lower, RR 0.55, p = 0.046, treatment 12 of 52 (23.1%), control 22 of 52 (42.3%), NNT 5.2, adjusted per study, propensity score matching, multivariable.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Kerr et al., 31 Dec 2021, retrospective, propensity score matching, Brazil, preprint, 9 authors, study period July 2020 - December 2020, dosage 200μg/kg days 1, 2, 16, 17, 0.2mg/kg/day for 2 days every 15 days.
Abstract: See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/357333781
COVID-19 In-Hospital Mortality Rate is Reduced by Prophylactic Use of
Ivermectin: Findings From a City-Wide, Prospective Observational Study
Using Propensity Score Matching (PSM)
Preprint · December 2021
DOI: 10.13140/RG.2.2.26793.52327
CITATION
READS
1
5,363
9 authors, including:
Lucy Kerr
Fernando Baldi
Instituto Kerr
São Paulo State University
11 PUBLICATIONS 93 CITATIONS
426 PUBLICATIONS 4,608 CITATIONS
SEE PROFILE
SEE PROFILE
Raysildo Barbosa Lôbo
Juan Chamie
Center for Genetic Engineering and Biotechnology
Universidad EAFIT
183 PUBLICATIONS 1,179 CITATIONS
8 PUBLICATIONS 11 CITATIONS
SEE PROFILE
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
ESTUDO DA VARIABILIDADE GENÉTICA DO PERFIL DE ACIDOS GRAXOS DA CARNE DE BOVINOS DA RAÇA NELORE TERMINADOS EM CONFINAMENTO View project
Análise genômica de bovinos da raça Nelore (Bos indicus) para características quantitativas e qualitativas de carcaça e carne View project
All content following this page was uploaded by Cadegiani Flávio on 26 December 2021.
The user has requested enhancement of the
1
COVID-19 In-Hospital Mortality Rate is Reduced by Prophylactic Use of
2
Ivermectin: Findings From a City-Wide, Prospective Observational Study Using
3
Propensity Score Matching (PSM)
4
5
6
Lucy Kerr, MD, ARDMS1, Fernando Baldi, PhD2, Raysildo Barbosa Lôbo, PhD3,
7
Washington Luiz Olivato Assagra4, Fernando Carlos Proença5, Jennifer A. Hibberd, DDS,
8
DPD, MRCDC6, Juan J Chamie-Quintero7, Pierre Kory, MD, MPA8, Flavio A. Cadegiani,
9
MD, MSc, PhD8,9*
10
11
12
13
14
15
16
17
18
19
20
21
1
Instituto Kerr de Ensino e Pesquisa, São Paulo, Brazil
Department of Animal Sciences, State University of São Paulo, São Paulo, Brazil
3
Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão
Preto, Brazil.
4
Centro Técnico de Avaliação Genômica C.T.A.G, Ribeirão Preto, Brazil
5
Itajaí City Hall, Itajaí, Brazil
6
University of Toronto, Toronto, Canada
7
Data Analysis, Universidad EAFIT, Cambridge, USA
8
Front-Line Covid-19 Critical Care Alliance (FLCCC), USA
9
Corpometria Institute, Brasilia, Brazil
2
22
23
24
25
26
27
28
29
*Corresponding author:
Flávio A. Cadegiani, MD, MSc, PhD
Corpometria Institute
SGAS 915 Centro Clínico Advance, Rooms 260/262/264, Brasília, DF, Brazil
f.cadegiani@gmail.com, flavio.cadegiani@unifesp.br, flavio@flccc.net
+55 61 981.395.395
30
31
Key-words: COVID-19, SARS-CoV-2, ivermectin, prophylaxis, prevention,
32
coronavirus
33
34
Acromyums: COPD = Chronic Obstructive Pulmonary Disease; CVD = cardiovascular
35
disease; MI = Myocardial infarction; T2D = Type 2 Diabetes
36
37
38
39
40
41
42
43
1
44
45
46
47
Abstract
48
vaccines, a medical-based citywide governmental program offered ivermectin
49
prophylaxis for COVID-19 (city of Itajaí, state of Santa Catarina, Southern Brazi). The
50
aim of the present study was to evaluate the impact of prophylactic ivermectin use in in-
51
hospital COVID-19 mortality rate.
52
Materials and methods: We analyzed data from hospitalized COVID-19 patients of a
53
major COVID-19 reference hospital during a city-wide program of ivermectin
54
prophylaxis for COVID-19 (Hospital Marieta Konder Bornhausen, Itajaí, Santa Catarina,
55
Brazil), between July and December 2020. We..
Loading..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.